Breaking New Ground in Oncology

We are charging ahead to transform the lives of patients, ease the burden of cancer on society, and restore hope.
Illustration of a T cell attacking a tumor cell
Illustration of a T cell attacking a tumor cell
We’re determined to develop powerful medicines, that are effective with the best possible safety profile, for people living with cancer. We’re confident we can do so by harnessing the potential of our proprietary drug discovery platforms.
Frank Nestle

Frank Nestle

Chief Scientific Officer

Layla Bral, Associate Scientist • LMR Ghent – Nanobody Research Platform Discovery, Belgium
Layla Bral, Associate Scientist • LMR Ghent – Nanobody Research Platform Discovery, Belgium

Our Oncology Pipeline

We have more than a dozen next-generation molecules in the clinic, each with a distinctive mechanism of action against either hematologic malignancies or solid tumors.

Follow the Science

Our R&D teams follow the science to find treatments for people living with cancer. 

Voices from the Lab: Nizar El Murr on Immuno-oncology

Our Multi-Front Attack on Cancer

John Reed and Frank Nestle discuss how we’re building an R&D pipeline to address critical gaps in cancer care

Bolstering the Immune System

Our immuno-oncology teams are working on ways to boost the immune system to better detect and attack tumors. And our molecular oncology teams are designing powerful precision drugs to either destroy cancer cells or activate immune cells locally.

Rethinking Oncology Drug Development

Our culture of collaboration empowers our teams to achieve real change for people battling cancer.

Technology Toolbox

We’ve reshaped our footprint in oncology, expanding our capabilities with state-of-the-art technologies in immuno-oncology, molecular oncology, and genomic medicine.


To further our bold vision of generating multiple candidates every year, we collaborate with innovative partners to break new ground in oncology.

Patient Centricity

By listening, learning, and keeping patients at the center of everything we do, we can advance the science and make a lasting difference in people’s lives.

More About Oncology

Cancer Under Siege

Sanofi’s Commitment to Oncology

Your Health: Oncology

Selected publications

  • LaMarche MJ (2022) Think Biologically, Act Chemically. J Medicinal Chem; DOI: 10.1021/acs.jmedchem.2c01121
  • Manandhar M, Chun E, Romesberg FE (2021) Genetic Code Expansion: Inception, Development, Commercialization. J Am Chem Soc 143:4859-4878; DOI: 10.1021/jacs.0c11938
  • Mitra-Kaushik S, Mehta-Damani A, Stewart JJ, et al. (2021) The Evolution of Single-Cell Analysis and Utility in Drug Development. AAPS J 23:98; DOI: 10.1208/s12248-021-00633-6

Page updated August 2023

MAT-GLB-2002356 v3.0 06/2023